Check Before You Invest : Link Pharma Chem Ltd

BSE: 524748 NSE: ISIN: INE302F01011

| Sector: Chemicals & Fertilizers | Industry: Chemicals

Snapshot

Q.1 Which industry/sub-sector does Link Pharma Chem Ltd belong to?

Link Pharma Chem Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.2 Is Link Pharma Chem Ltd a good quality company?

Link Pharma Chem Ltd is a quality company, based on a 10-year financial track record.

Q.3 Is Link Pharma Chem Ltd undervalued or overvalued?

Link Pharma Chem Ltd appears Fair, as its key valuation ratios are in line with their past averages.

Q.4 Is Link Pharma Chem Ltd a good buy now?

Link Pharma Chem Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Link Pharma Chem Ltd?

Link Pharma Chem Ltd revenue growth is -15% for FY-2025, which is below its 5-year CAGR of -0.03%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Return on capital employed is -3.03% for FY-2025, which is below its 5-year historical median of 7.38%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Return on Asset is -4.19%, which is below its 5-year historical median of 2.13%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Return on equity is -7.79% for FY-2025, which is below its 5-year historical median of 4.43%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Cash conversion cycle is 117 days, above its 5-year historical median of 68 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	1.04	1.26
ROE	-7.79	4.43
ROCE	-3.03	7.38
Cash Conversion Cycle	117 days	68 days

Q.6 Gross Profit margin of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Gross profit margin which is the profit after deduction of direct costs, is -1.8% for FY-2025, which is below its 5-year median of 4.7%, indicating decreasing margins.

Q.7 Operating Profit Margin of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 0.51% for FY-2025, which is below its 5-year median of 6.54% indicating decreasing margins.

Q.8 Net Profit Margin of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Net Profit Margin is -4.04% for FY-2025, is below with its 5-year median of 1.69%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	-1.8	4.7
Operating Profit Margin	0.51	6.54
Net Profit Margin	-4.04	1.69

Q.9 Debt to Equity ratio of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Debt-to-Equity ratio is 0.46, which is above with the industry average of 0.26, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Link Pharma Chem Ltd?

Link Pharma Chem Ltd Debt to cash flow from operations is 2.15, which is at a moderate level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Link Pharma Chem Ltd?

Promoters hold 52.40% of the Link Pharma Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Link Pharma Chem Ltd vs industry peers?

Link Pharma Chem Ltd revenue CAGR is -0.03%, compared to the industry median CAGR of 9.62%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-15	9.6
Gross Profit Growth	0	14.3
Operating Profit Growth	0	12
Net Profit Growth	0	12.7

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	1.04	0.97
ROE	-7.79	10.68
ROCE	-3.03	13.26
Cash Conversion Cycle (days)	117.21	63

Valuation & price assessment

Q.1 Stock return of Link Pharma Chem Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 12.8% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	12.8%	-3.4%	-10.3%	-19.1%

Q.3 Valuation ratios of Link Pharma Chem Ltd vs historical?

The current P/E is higher that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	97.43	15.67	27.93
Price to Book	0.99	1.28	2.22
Price to Sales	0.48	0.54	1.93
EV to EBITDA	12.01	7.83	14.18

Check more companies

1. Navin Fluorine Intl

2. Godrej Industries

3. Deepak Nitrite

4. Tata Chemicals

5. Atul

6. Aarti Inds

7. Aether Industries

8. Deepak Fert & Petro

9. BASF India

10. Anupam Rasayan India

Check trending companies

1. Samvardhana Motherson International Ltd.

2. Jindal Saw Ltd.

3. Union Bank Of India

4. Lloyds Metals & Energy Ltd.

5. Astral Ltd.